Emergency Department Visits for Adverse Drug Reactions Involving Alcohol: United States, 2005 to 2011

Alcoholism: Clinical and Experimental Research

Volumn 40, Issue 9, 2016, Pages 1913-1925

  Castle, I Jen P ^a   Dong, Chuanhui ^a,b   Haughwout, Sarah P ^a   White, Aaron M ^c  

^a CSR INCORPORATED   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Adverse Drug Reactions; Age Differences; Alcohol; Emergency Department Visits; Sex Differences

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; ALCOHOL; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; HYPNOTIC AGENT; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEDATIVE AGENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ALCOHOL CONSUMPTION; ARTICLE; CHILD; DRUG ABUSE; DRUG MONITORING; EMERGENCY WARD; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREND STUDY; UNITED STATES; DRINKING BEHAVIOR; EMERGENCY HEALTH SERVICE; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; RETROSPECTIVE STUDY; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; ALCOHOL DRINKING; CHILD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84984788886     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.13167     Document Type: Article

References (55)

1. Bach LE, Mortimer JA, VandeWeerd C, Corvin J (2013) The association of physical and mental health with sexual activity in older adults in a retirement community. J Sex Med 10:2671–2678.
2. Barkla XM, McArdle PA, Newbury-Birch D (2015) Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature. BMC Psychiatry 15:270.
3. Bolton JM, Robinson J, Sareen J (2009) Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord 115:367–375.
4. Breslow RA, Dong C, White A (2015) Prevalence of alcohol-interactive prescription medication use among current drinkers: United States, 1999 to 2010. Alcohol Clin Exp Res 39:371–379.
5. Brown RL, Dimond AR, Hulisz D, Saunders LA, Bobula JA (2007) Pharmacoepidemiology of potential alcohol–prescription drug interactions among primary care patients with alcohol-use disorders. J Am Pharm Assoc 47:135–139.
6. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296:1858–1866.
7. Center for Behavioral Health Statistics and Quality (2013a) Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Substance Abuse and Mental Health Services Administration, Rockville, MD. Available at: http://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.htm. Accessed January 28, 2016.
8. Center for Behavioral Health Statistics and Quality (2013b) Drug Abuse Warning Network, 2011: Selected Tables of National Estimates of Drug-Related Emergency Department Visits. Substance Abuse and Mental Health Services Administration, Rockville, MD. Available at: http://www.samhsa.gov/data/sites/default/files/Nation_2011_All.xls. Accessed January 25, 2016.
9. Center for Behavioral Health Statistics and Quality (2013c) Drug Abuse Warning Network Methodology Report, 2011 Update. Substance Abuse and Mental Health Services Administration, Rockville, MD. Available at: http://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/rpts/DAWN2k11-Methods-Report.pdf. Accessed January 22, 2016.
10. Center for Behavioral Health Statistics and Quality (2014) The DAWN Report: Benzodiazepines in Combination with Opioid Pain Relievers or Alcohol: Greater Risk of More Serious ED Visit Outcomes. Substance Abuse and Mental Health Services Administration, Rockville, MD. Available at: http://www.samhsa.gov/data/sites/default/files/DAWN-SR192-BenzoCombos-2014/DAWN-SR192-BenzoCombos-2014.pdf. Accessed February 26, 2016.
11. Chan KK, Neighbors C, Gilson M, Larimer ME, Alan Marlatt G (2007) Epidemiological trends in drinking by age and gender: providing normative feedback to adults. Addict Behav 32:967–976.
12. Chen CM, Dufour MC, Yi H (2004/2005) Alcohol consumption among young adults ages 18–24 in the United States: results from the 2001–2002 NESARC survey. Alcohol Res Health 28:269–280.
13. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365:1896–1904.
14. Eaton NR, Thompson RG Jr, Hu MC, Goldstein RB, Saha TD, Hasin DS (2015) Regularly drinking alcohol before sexual activity in a nationally representative sample: prevalence, sociodemographics, and associations with psychiatric and substance use disorders. Am J Public Health 105:1387–1393.
15. Food and Drug Administration (FDA) (2009) Label Information of Wellbutrin. FDA, Washington, DC. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018644s041MedGuide.pdf. Accessed February 26, 2016.
16. Food and Drug Administration (FDA) (2015) Label Information of Oxycontin. FDA, Washington, DC. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022272s027lbl.pdf. Accessed February 26, 2016.
17. Food and Drug Administration (FDA) (2016) Label Information of Cialis. FDA, Washington, DC. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021368s027lbl.pdf. Accessed July 25, 2016.
18. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS (1990) High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322:95–99.
19. Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS (2015) Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry 72:757–766.
20. Gu Q, Dillon CF, Burt VL (2010) Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007–2008. NCHS Data Brief, No 42. National Center for Health Statistics, Hyattsville, MD. Available at: http://www.cdc.gov/nchs/data/databriefs/db42.pdf. Accessed January 15, 2016.
21. Harris RZ, Benet LZ, Schwartz JB (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222–239.
22. Harris SK, Knight JR (2014) Putting the screen in screening: technology-based alcohol screening and brief interventions in medical settings. Alcohol Res 36:63–79.
23. Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, Purssell RA (2010) Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med 55:493–502. e4.
24. Jones AW (2003) Alcohol and drug interactions, in Handbook of Drug Interactions: A Clinical and Forensic Guide (Mozayani A, Raymon LP eds), pp 395–462. Springer Science & Business Media, New York, NY.
25. Jones CM, Paulozzi LJ, Mack KA; Centers for Disease Control and Prevention (2014) Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths—United States, 2010. MMWR Morb Mortal Wkly Rep 63:881–885.
26. Kanny D, Liu Y, Brewer RD, Lu H (2013) Binge drinking—United States, 2011. MMWR Suppl 62:77–80.
27. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL (2015) Trends in prescription drug use among adults in the United States from 1999–2012. JAMA 314:1818–1831.
28. Karlamangla A, Zhou K, Reuben D, Greendale G, Moore A (2006) Longitudinal trajectories of heavy drinking in adults in the United States of America. Addiction 101:91–99.
29. Kaufman DW, Kelly JP, Wiholm B-E, Laszlo A, Sheehan JE, Koff RS, Shapiro S (1999) The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol 94:3189–3196.
30. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351.
31. Kuperman GJ, Bobb A, Payne TH, Avery AJ, Gandhi TK, Burns G, Classen DC, Bates DW (2007) Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 14:29–40.
32. Leeies M, Pagura J, Sareen J, Bolton JM (2010) The use of alcohol and drugs to self-medicate symptoms of posttraumatic stress disorder. Depress Anxiety 27:731–736.
33. McKnight-Eily LR, Liu Y, Brewer RD, Kanny D, Lu H, Denny CH, Balluz L, Collins J (2014) Vital signs: communication between health professionals and their patients about alcohol use—44 states and the District of Columbia, 2011. MMWR Morb Mortal Wkly Rep 63:16–22.
34. Moore AA, Whiteman EJ, Ward KT (2007) Risks of combined alcohol/medication use in older adults. Am J Geriatr Pharmacother 5:64–74.
35. Moore N, Pollack C, Butkerait P (2015) Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag 11:1061–1075.
36. National Cancer Institute (2015) Joinpoint Regression Program, Version 4.2.0.2 June 2015. Statistical Methodology and Applications Branch, National Cancer Institute, Bethesda, MD.
37. National Center for Health Statistics (NCHS) (2014) Health, United States, 2013: With Special Feature on Prescription Drugs. NCHS, Hyattsville, MD. Available at: http://www.cdc.gov/nchs/data/hus/hus13.pdf. Accessed February 25, 2016.
38. National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2014) Harmful Interactions: Mixing Alcohol with Medicines. NIH Publication No. 13-5329. NIAAA, National Institutes of Health, Bethesda, MD. Available at: http://pubs.niaaa.nih.gov/publications/Medicine/Harmful_Interactions.pdf. Accessed January 27, 2016.
39. National Institute on Alcohol Abuse and Alcoholism (NIAAA) (n.d.) NIAAA Clinician's Guide Online Training. NIAAA, Bethesda, MD. Available at: http://www.niaaa.nih.gov/publications/clinical-guides-and-manuals/niaaa-clinicians-guide-online-training. Accessed March 3, 2016.
40. Pharmacia and Upjohn Company (2013) Xanax U.S. Physician Prescribing Information. Pfizer Inc, New York, NY. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=547. Accessed July 25, 2016.
41. Riper H, Andersson G, Hunter SB, de Wit J, Berking M, Cuijpers P (2014) Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis. Addiction 109:394–406.
42. Robinson J, Sareen J, Cox BJ, Bolton J (2009a) Self-medication of anxiety disorders with alcohol and drugs: results from a nationally representative sample. J Anxiety Disord 23:38–45.
43. Robinson JA, Sareen J, Cox BJ, Bolton JM (2009b) Correlates of self-medication for anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Nerv Ment Dis 197:873–878.
44. Samal L, Dykes PC, Greenberg JO, Hasan O, Venkatesh AK, Volk LA, Bates DW (2016) Care coordination gaps due to lack of interoperability in the United States: a qualitative study and literature review. BMC Health Serv Res 16:143.
45. Sellers EM, Holloway MR (1978) Drug kinetics and alcohol ingestion. Clin Pharmacokinet 3:440–452.
46. Sites BD, Beach ML, Davis MA (2014) Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med 39:6–12.
47. Substance Abuse and Mental Health Services Administration (n.d.) Drug Abuse Warning Network (DAWN) Series. ICPSR Series 97. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI. Available at: http://www.icpsr.umich.edu/icpsrweb/ICPSR/series/97. Accessed January 22, 2016.
48. Substance Abuse and Mental Health Services Administration (SAMHSA) (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. SAMHSA, Rockville, MD. Available at: http://www.samhsa.gov/data/sites/default/files/Revised2k11NSDUHSummNatFindings/Revised2k11NSDUHSummNatFindings/NSDUHresults2011.htm#3.1 Accessed November 12, 2015.
49. Tanaka E (2003) Toxicological interactions involving psychiatric drugs and alcohol: an update. J Clin Pharm Ther 28:81–95.
50. Thomasson HR (1995) Gender differences in alcohol metabolism: physiological responses to ethanol. Recent Dev Alcohol 12:163–179.
51. Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, Perou R, Blumberg SJ (2014) Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. J Am Acad Child Adolesc Psychiatry 53:34–46.e2.
52. Weathermon R, Crabb DW (1999) Alcohol and medication interactions. Alcohol Res Health 23:40–54.
53. White A, Castle I-JP, Chen CM, Shirley M, Roach D, Hingson R (2015) Converging patterns of alcohol use and related outcomes among females and males in the United States, 2002 to 2012. Alcohol Clin Exp Res 39:1712–1726.
54. Wilsnack RW, Wilsnack SC, Kristjanson AF, Vogeltanz-Holm ND, Gmel G (2009) Gender and alcohol consumption: patterns from the multinational GENACIS project. Addiction 104:1487–1500.
55. Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S (2011) ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128:1007–1022.